Discovery Labs Soars on Surfaxin Approval - Mar. 7, 2012

Having trouble viewing this email? View in Browser.

Wednesday, March 07, 2012  |   |   |   |  Aptuit is a pharmaceutical services company that delivers early to mid-phase drug development solutions by applying scientific excellence, outstanding service and the industry's best team of people. Please click here for more information . •  Discovery Laboratories (DSCO) Soars on Surfaxin Approval More... More Drug Approval News •  FDA Rejects Eisai Inc. (ESALF.PK)' Dacogen for AML, Looks at Epilepsy Drug Again More... •  Viral Genetics Inc. (VRAL) Submits Pre-IND Document for Lyme Disease Drug Candidate to FDA More... More BLA/NDA/ANDA News More IND News More MAA News •  Vertex Pharmaceuticals (MA) (VRTX), Merck & Co., Inc. (MRK) Hepatitis Drugs Work in HIV Patients More... •  More Patients Relapse in Gilead Sciences, Inc. (GILD) Hepatitis C Trial More... •  Forest Laboratories, Inc. (FRX) and Pierre Fabre Medicament Announce Positive Phase III Results For Levomilnacipran in Patients With Major Depressive Disorder More... •  Sucampo Pharmaceuticals, Inc. Release: Phase 3 Long-Term Safety Trial Results of Lubiprostone in Patients with Irritable Bowel Syndrome with Constipation was Recently Published in Alimentary Pharmacology and Therapeutics More... •  AcelRx Pharmaceuticals Announces Initiation of Phase 3 Clinical Program for ARX-01, the Sufentanil NanoTab(R) PCA System for the Treatment of Post-Operative Pain More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! •  Estrogen-Only Therapy May Reduce Breast Cancer Risk, Fred Hutchinson Cancer Research Center Study More... •  With the Right Photo, Your Facebook Text Profile Hardly Matters, Ohio State University Study More... •  Researchers Find Yoga Helps Ease Stress Related Medical and Psychological Conditions, Boston University School of Medicine Study More... •  Arrowhead Research Corporation (ARWR) Releases White Paper on Hepatitis B Virus and Potential RNAi Treatment More... •  New Data Indicate Pressure BioSciences, Inc. (BBII)' Novel Technology Platform Offers Great Promise to the Areas of Biomarker Discovery and Drug Development More... More General Clinical Research News CHI's World Pharma Congress 2012 encompasses a broad spectrum of topics that are very important and relevant to scientists in academia as well as those in the pharmaceutical and biotechnology industry. Building on last year's focus on the pre-clinical activities, the conferences continue to cover topics around drug discovery for various therapeutic areas (Parkinson's Disease, Alzheimer's Disease, Pain), technologies related to discovery and development (Preclinical Models in Oncology and Molecular Imaging) and topics related to drug safety (Cardiotoxicity and Hepatotoxicity). The conferences all offer informative and pragmatic viewpoints for tackling issues relevant to chemists, biologists, pharmacologists, toxicologists and clinicians alike. Each conference features presentations, interactive panels and technology talks that cover the very latest on the topic, both on the scientific and the technical side. The World Pharma Congress continues to offer attendees and exhibitors ample opportunity to network, brainstorm and collaborate on various fronts. Visit WorldPharmaCongress.com for complete details. Biomarkers in Late Stage Clinical Trials • Quantify and analyze revenues of late stage biomarker technology and services in North America, Europe, Asia and the Rest of the World. • Identify the key market drivers and resistors of the biomarker market and evaluate the growth potential of emerging technologies. • Assess biomarker activity at leading companies, including Abbott, AZ, BMS, Eli Lilly, GSK, Merck & Co, Novartis, Pfizer, Roche and Sanofi-Aventis. Click Here for More Information. • Biotech Beach (Irvine, California) Allergan Inc. Senior Manager, Clinical Business Operations Oversees and ensures the successful execution many central business processes which enable the execution of clinical studies. The CS Manager may be responsible for contracting, vendor management, Beacon system support, Impact system support, metrics reporting, and/or budget & forecast development and support. • BioMidwest (Hinckley, Ohio) Clinical Research Management, Inc. Clinical Research Associate Manage the development, coordination, and implementation of clinical operations site management and clinical monitoring responsibilities for assigned projects with guidance, including trial-specific processes and systems. • Biotech Bay (Novato, California) BioMarin Pharmaceutical Inc. Senior Medical Director, Clinical Science Will report to the Vice President of Clinical Science, needs to be proficient in clinical study, program design and execution. Experience and knowledge in interaction with clinical investigators, collaboration with regulatory affairs, and FDA interactions is required. • Genetown (Lexington, Massachusetts) Cubist Pharmaceuticals, Inc. Senior Manager/Manager, Clinical Trial GCP Compliance Will assist with the development, implementation and maintenance of a proactive GCP compliance management system, including the development of processes and standards, training, and ensuring that regulatory requirements (ICH, FDA, EMA, etc.) and guidelines are adhered to. • BioTechxus (Austin, Texas) Genprex, Inc. Clinical Research Consultant Will involve interacting with technical development teams and contract manufacturing organizations (CMOs), developing and presenting technical recommendations to the Management Team, recommending clinical trial strategies, and preparing CMC documentation for regulatory submissions. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! BioSpace Career Fair at CALBIO2012 Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Bay Area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • BioSpace Career Fair at CALBIO2012, San Francisco, CA March 7, 2012 • BioMidwest Career Fair, Bridgewater, NJ March 22, 2012 • Biotech Beach Career Fair, La Jolla, CA April 17, 2012 • BioCapital Career Fair, Bethesda, MD April 25, 2012 • Pharm Country Career Fair, King Of Prussia, PA May 1, 2012 • BioNC Career Fair, Durham, NC May 2, 2012 • Biotech Bay Career Fair, Burlingame, CA May 29, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services •  Pernix Therapeutics, Inc. (PTX)' Subsidiary Macoven Pharmaceuticals, LLC Named in Suit by Merck, Pamlab LLC and Others for Alleged Patent Violations More... •  BioLineRx Ltd. Announces Grant of European Patent Covering BL-1020, an Orally Available Treatment for Schizophrenia More... •  USPTO Rejects Butamax's Self-Described "Foundational" IP Claims in Successful Gevo, Inc. Reexamination Petition More... •  US Patent Office Rejection of All Claims in Final Asserted MonoSol Patent Further Supports BioDelivery Sciences International (BDSI)' Position More... •  Skinvisible, Inc. (SKVI) Granted US Sunscreen Patent for UVA Absorber More... More Patent News •  Novartis AG (NVS)' Gilenya Pill Loses Market Share as Doctors Become Wary More... •  Fera Pharmaceuticals Announces Launch of a New Ophthalmic Anti-Infective More... •  Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (LLY)'s New Oral Type 2 Diabetes Treatment for Adults, Jentadueto™ (linagliptin/metformin hydrochloride) Tablets, Now Available in U.S. Pharmacies More... More Drug Product News Hot Company Alder Biopharmaceuticals Inc. Corporate Headquarters 11804 North Creek Parkway South Bothell, Washington 98011 U.S.A. Phone: 425-205-2900 Fax: 425-205-2901 Alder is revolutionizing the way antibody therapies are identified, selected, developed and produced. Our proprietary technologies make great strides possible in the field of antibody therapeutics, dramatically accelerating the way pharmaceutical and biotechnology companies bring new therapies to market. More Company Profiles Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.